NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-10-15
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
Living Fair Value by QuarterlyIQ
A valuation that evolves as the business changes.
A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.
View Living FV report and workflowThree key conditions need to be met for the investment thesis to play out.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Revenue growth to improve from $1.88M in 2026-Q1 | A primary condition in FUSEMACHINES INC's published investment case. The stated target is >1.88 million USD next 4 quarters. | Under Pressure | revenue falls below $1.88M over next 4 quarters | Revenue: $1.794M FY2026-Q2; GAAP. Published target: >1.88 million USD next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 7, 20261,794,000 USD · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: ddc9432a-36c7-403a-a6e1-e1db62e46d5a. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 4 quarters. Operating income improved slightly from -$3.04M in 2026-Q1 to -$2.69M in 2026-Q2, but net income declined from -$0.87M to -$2.85M. Despite management focus on reducing losses, net income trajectory is declining while operating losses show limited improvement, indicating mixed progress. Delivery assessment Oct 15, 2026 |
Avoid Nasdaq delisting and maintain listing standards | A supporting condition in FUSEMACHINES INC's published investment case. The stated target is No delisting notices or failures to meet Nasdaq rules next 4 quarters. | Under Pressure | receives new Nasdaq delisting notices or fails listing rules | 2 active delisting notices vs 0 target Nasdaq issued notices for MVLS and bid price failures in Sept 2026; stock at $0.38. Context reviewed through Oct 15, 2026Last status assessment Oct 15, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Reduce operating loss from -$3.04M in 2026-Q1 | A primary condition in FUSEMACHINES INC's published investment case. The stated target is operating loss > -3.04 million USD next 4 quarters. | Broken | operating loss worsens beyond -$3.04M over next 4 quarters | Operating income: $-2.69M FY2026-Q2; GAAP. Published target: operating loss > -3.04 million USD next 4 quarters. Target period is not explicitly aligned with this observation. Source published Aug 7, 2026-2,690,000 USD · source valueSource reportLast status assessment Oct 15, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: ddc9432a-36c7-403a-a6e1-e1db62e46d5a. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 4 of last 4 quarters. Operating income improved slightly from -$3.04M in 2026-Q1 to -$2.69M in 2026-Q2, but net income declined from -$0.87M to -$2.85M. Despite management focus on reducing losses, net income trajectory is declining while operating losses show limited improvement, indicating mixed progress. Delivery assessment Oct 15, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 16–Oct 15 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 6, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a speculative growth opportunity. The current thesis state is cautious, as the company has shown mixed management execution and elevated risks in recent months.
The market appears to price in a low level of fragility, suggesting that while there are risks, they are not fully reflected in the current valuation. FUSE is considered cheap compared to its peers, but the low confidence in its financial model indicates that expectations may be tempered.
Fundamentals are likely to remain weak in the near term, as recent financial performance has not met industry standards. Management's focus on growth and compliance issues adds uncertainty to the company's trajectory.
The long-term thesis hinges on several factors, including the potential for favorable market conditions if the Fed cuts rates and the performance of sector leaders like SAP and CRM. Conversely, negative guidance or continued regulatory challenges could significantly impact investor sentiment.
In the next 1 to 3 years, FUSE's outlook will depend on its ability to navigate regulatory hurdles and improve financial performance amidst sector trends. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.